179 Results

People

  1. Motzer
    Motzer
  2. De Angelis
    De Angelis
  3. Abrey
    Abrey
  4. Panageas
    Panageas
  5. Giralt
    Giralt
  6. Kris
    Kris
  7. Sauter
    Sauter
  8. Beal
    Beal
  9. Omuro
    Omuro
  10. Perales
    Perales

Groups

  1. Department of Medicine (102)
  2. Solid Tumor Oncology Division (66)
  3. Epidemiology and Biostatistics (46)
  4. Survivorship Research (44)
  5. Biostatistics Service (43)
  6. Hematologic Malignancies, Division of (41)
  7. Center for Hematologic Malignancies (39)
  8. Population Sciences Research Program (30)
  9. Genitourinary Oncology Service (28)
  10. Radiation Oncology, Department of (27)
  1. "karnofsky performance status"
Formats
  1. Journal Article (168)
  2. Review (5)
  3. Research Letter (2)
  4. Conference Paper (1)
  5. Correspondence (1)
  6. Editorial (1)
  7. Guidelines (1)
Groups
  1. Department of Medicine (102)
  2. Solid Tumor Oncology Division (66)
  3. Epidemiology and Biostatistics (46)
  4. Survivorship Research (44)
  5. Biostatistics Service (43)
  6. Hematologic Malignancies, Division of (41)

More Groups

People
  1. Robert Motzer (19)
  2. Lisa De Angelis (18)
  3. Lauren Abrey (17)
  4. Katherine Panageas (14)
  5. Sergio Giralt (10)
  6. Mark Kris (9)

More People

Years
  1. 2025 (8)
  2. 2024 (19)
  3. 2023 (8)
  4. 2022 (8)
  5. 2021 (4)
  6. 2020 (8)

More Years

Publications
  1. Journal of Neuro-Oncology (17)
  2. Journal of Clinical Oncology (16)
  3. Cancer (10)
  4. International Journal of Radiation Oncology, Biology, Physics (8)
  5. Annals of Oncology (6)
  6. Transplantation and Cellular Therapy (6)

More Publications

Publishers
  1. Elsevier Inc. (35)
  2. Springer (24)
  3. American Society of Clinical Oncology (17)
  4. Oxford University Press (15)
  5. Wiley Blackwell (13)
  6. Elsevier Science, Inc. (12)

More Publishers

Results (179)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Symptom clusters and their impact on quality of life in multiple myeloma survivors: Secondary analysis of BMT CTN 0702 trial
    Journal Article

    Brazauskas, R.; Flynn, K.; Krishnan, A.; Landau, H.; Giralt, S.; Pasquini, M. C.; Stadtmauer, E. A.; D'Souza, A.
    British Journal of Haematology (2024)

    Fulltext@MSK | Save
  • Prophylactic radiation therapy for high-risk asymptomatic bone metastases: A new standard of care or need for more data?
    Correspondence

    Chan, A. W.; Simone, C. B.; Van Der Linden, Y.; Hoskin, P.; Detsky, J.; Choi, J. I.; Lee, S. F.; Wong, H. C. Y.; Martin, E. J.; Raman, S.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Targeting refractory/recurrent neuroblastoma and osteosarcoma with anti-CD3×anti-GD2 bispecific antibody armed T cells
    Journal Article

    Yankelevich, M.; Thakur, A.; Modak, S.; Chu, R.; Taub, J.; Martin, A.; Schalk, D.; Schienshang, A.; Whitaker, S.; Rea, K.; more...
    Journal for ImmunoTherapy of Cancer (2024)

    Fulltext@MSK | Save
  • Effects of androgen deprivation therapy on prostate cancer outcomes according to competing event risk: Secondary analysis of a phase 3 randomised trial
    Journal Article

    Mell, L. K.; Pugh, S. L.; Jones, C. U.; Nelson, T. J.; Zakeri, K.; Rose, B. S.; Zeitzer, K. L.; Gore, E. M.; Bahary, J. P.; Souhami, L.; more...
    European Urology (2024)

    Fulltext@MSK | Save
  • Next-generation therapies for pancreatic cancer
    Review

    Buckley, C. W.; O’Reilly, E. M.
    Expert Review of Gastroenterology and Hepatology (2024)

    Fulltext@MSK | Save
  • Clinical and dosimetric risk factors associated with radiation-induced lung toxicities after multiple courses of lung stereotactic body radiation therapy
    Journal Article

    Li, X.; Yorke, E.; Jackson, A.; Yue, Y.; Simone, C. B. 2nd; Apte, A. P.; Rimner, A.; Gomez, D. R.; Shaverdian, N.; Gelblum, D. Y.; more...
    Advances in Radiation Oncology (2024)

    Fulltext@MSK | Save
  • Indication and management of allogeneic haematopoietic stem-cell transplantation in myelofibrosis: Updated recommendations by the EBMT/ELN International Working Group
    Review

    Kröger, N.; Bacigalupo, A.; Barbui, T.; Ditschkowski, M.; Gagelmann, N.; Griesshammer, M.; Gupta, V.; Hamad, N.; Harrison, C.; Hernandez-Boluda, J. C.; more...
    The Lancet Haematology (2024)

    Fulltext@MSK | Save
  • Phase I trial of panobinostat in children with diffuse intrinsic pontine glioma: A report from the Pediatric Brain Tumor Consortium (PBTC-047)
    Journal Article

    Monje, M.; Cooney, T.; Glod, J.; Huang, J.; Peer, C. J.; Faury, D.; Baxter, P.; Kramer, K.; Lenzen, A.; Robison, N. J.; more...
    Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • Clinical, histological, and molecular features of gliomas in adults with neurofibromatosis type 1
    Journal Article

    Romo, C. G.; Piotrowski, A. F.; Campian, J. L.; Diarte, J.; Rodriguez, F. J.; Bale, T. A.; Dahiya, S.; Gutmann, D. H.; Lucas, C. H. G.; Prichett, L.; more...
    Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • Brentuximab vedotin with AVD for stage II–IV HIV-related Hodgkin lymphoma (AMC 085): Phase 2 results from an open-label, single arm, multicentre phase 1/2 trial
    Journal Article

    Rubinstein, P. G.; Moore, P. C.; Bimali, M.; Lee, J. Y.; Rudek, M. A.; Chadburn, A.; Ratner, L.; Henry, D. H.; Cesarman, E.; DeMarco, C. E.; more...
    The Lancet Haematology (2023)

    Fulltext@MSK | Save